US Patent Issued on July 15 for "Bioresorbable, implantable device having controlled drug delivery" (Delaware Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,480, issued on July 15.

"Bioresorbable, implantable device having controlled drug delivery" was invented by John James Scanlon (Wilmington, Del.) and Catherine Ann Scanlon (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A bioresorbable, implantable device having controlled drug delivery is disclosed herein. The bioresorbable, implantable device is configured as a film, a roll, a tube, and a stent. The bioresorbable, implantable device is configured to release an active ingredient (the "drug") from the bioresorbable, implantable device when the bioresorbable, implantable device is implanted within a body. The bioresorbable, implantab...